Enovis to Participate in Upcoming Investor Conferences
June 06, 2025 16:05 ET | Source: Enovis Corporation Wilmington, DE, June…
ZEISS CLARUS 700 Receives NMPA Approval in China
ZEISS Medical Technology expands retinal insights for ophthalmologists with ultra-widefield, high-resolution imaging…
Bybit donates over $300,000 to support earthquake relief in Myanmar and Thailand
DUBAI, UAE, June 5, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
Helius Medical Technologies Announces Pricing of $9.1 Million Public Offering
June 04, 2025 21:12 ET | Source: Helius Medical Technologies, Inc. NEWTOWN,…
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 05, 2025 (GLOBE…
Miles Education and St. James School of Medicine partner to enable Indian NEET Qualifiers to become Licensed U.S. Doctors
BANGALORE, India, June 4, 2025 /PRNewswire/ -- Miles Education, a global ed-tech leader…
Continuity Biosciences Acquires Focal Medical to Advance Targeted Drug Delivery for Pancreatic Cancer
BRADENTON, Fla., June 4, 2025 /PRNewswire/ -- Continuity Biosciences, LLC, a developer…
New Potential Treatment Strategy for Brain Metastases and Leptomeningeal Disease: HER3-DXd Shows Promising Results in the Phase II TUXEDO-3 Study for Patients With Limited Therapeutic Options
The TUXEDO-3 trial is the first study to evaluate the intracranial and…
Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease
Rilzabrutinib granted orphan drug designation in the US for sickle cell disease…
Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
46% reduction in the risk of disease progression or death, and 27%…